Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells
- 31 January 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 479, 61-70
- https://doi.org/10.1016/j.canlet.2020.01.039
Abstract
No abstract availableKeywords
Funding Information
- Else Kröner-Fresenius-Stiftung
- Deutsche Krebshilfe
- Adenoid Cystic Carcinoma Research Foundation
- Swedish Cancer Society
- Swedish Childhood Cancer Fund
- Swedish state (ALFGBG-721711)
This publication has 57 references indexed in Scilit:
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Target Identification Using Drug Affinity Responsive Target Stability (DARTS)Current Protocols in Chemical Biology, 2011
- Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic reviewThe Lancet Oncology, 2011
- Molecular Interaction Studies Using Microscale ThermophoresisASSAY and Drug Development Technologies, 2011
- A SUMO-regulated activation function controls synergy of c-Myb through a repressor–activator switch leading to differential p300 recruitmentNucleic Acids Research, 2010
- Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neckProceedings of the National Academy of Sciences of the United States of America, 2009
- Adenovirus E1A Inhibits SCFFbw7 Ubiquitin LigaseOnline Journal of Public Health Informatics, 2009
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem CellsCell Stem Cell, 2009
- Fbxw7 Acts as an E3 Ubiquitin Ligase That Targets c-Myb for Nemo-like Kinase (NLK)-induced Degradation*Online Journal of Public Health Informatics, 2008
- Duplication of the MYB oncogene in T cell acute lymphoblastic leukemiaNature Genetics, 2007